Tandem Diabetes Care Financial Ratios
TNDM / Health Care|FY2025 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2025 SEC 10-K data.
Key Data Points
- Altman Z-Score -0.32 (distress zone, below 1.8 threshold)
- Negative profit margin: -20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2025)
Return on Equity
-131.9%
Profit Margin
-20.2%
Net Income / Revenue
Asset Turnover
1.15
Revenue / Total Assets
Equity Multiplier
5.68
Total Assets / Equity
Composite: -131.9% (reported: -131.9%)
Profitability
Liquidity
Current Ratio
2.55
Quick Ratio
2.02
Solvency
Interest Coverage
-
Efficiency
Asset Turnover
1.15
Inventory Turnover
3.64
Days Sales Outstanding
60 days
As of FY2025 · SEC 10-K · Updated Jun 30, 2026
Earnings Quality
Accrual Ratio
-21.1%
-8.7pp YoY
Earnings are primarily supported by operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.